Gene · 442891
Papers2,355
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,355
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significance of MALAT1 long non-coding RNA and miR-20a-5p in regulating epithelial mesenchymal transition in luminal breast cancer patients. | J Egypt Natl Canc Inst | 2026 | 41622408 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Research progress and application prospect of engineered small extracellular vesicles. | Cell Transplant | 2026 | 41562261 | PubTator, text mining | PubMed |
| <p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>. | Oncol Rep | 2026 | 41543186 | PubTator, text mining | PubMed |
| Comprehensive analysis of mRNA-microRNA-lncRNA expression profiles in post-traumatic elbow heterotopic ossification using RNA sequencing and experimental validation. | Ann Med | 2026 | 41530916 | PubTator, text mining | PubMed |
| The interplay between the extracellular matrix and extracellular vesicle-associated microRNAs. | Cell Commun Signal | 2026 | 41495757 | PubTator, text mining | PubMed |
| Descriptive transcriptomic profiling differentiates oral leukoplakia from proliferative verrucous leukoplakia and reveals distinct molecular signatures. | Med Oral Patol Oral Cir Bucal | 2026 | 41273738 | PubTator, text mining | PubMed |
| Effects of acupuncture and moxibustion therapy on endometrial receptivity of infertile women with in vitro fertilization-embryo transfer: status quo and countermeasures. | Front Med (Lausanne) | 2025 | 41743455 | PubTator, text mining | PubMed |
| Influence of Reference Gene Selection on miRNA Quantification by RT-qPCR in Human Placental Samples. | Br J Biomed Sci | 2025 | 41425138 | PubTator, text mining | PubMed |
| Erratum: LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC [Corrigendum]. | Biologics | 2025 | 41404044 | PubTator, text mining | PubMed |
| MicroRNAs in BM-MSC-Derived Extracellular Vesicles Promote Angiogenesis: An in Vitro Model Study. | Biomedicines | 2025 | 41153640 | PubTator, text mining | PubMed |
| Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers. | Mol Cancer | 2025 | 41063167 | PubTator, text mining | PubMed |
| Overexpressed miR-135b in the ovaries of PCOS promotes granulosa cell proliferation by inhibiting Hippo signaling pathway. | J Assist Reprod Genet | 2025 | 41045336 | PubTator, text mining | PubMed |
| Janus Hydrogels: Design, Properties, and Applications. | Gels | 2025 | 41002492 | PubTator, text mining | PubMed |
| Cellular Delivery of Functional AntimiR Conjugated to Bio-Produced Gold Nanoparticles. | Noncoding RNA | 2025 | 40981383 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| [Expression of Concern] miR‑135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. | Int J Oncol | 2025 | 40970336 | PubTator, text mining | PubMed |
| Identifying potential miRNA-disease associations through an accurate matrix completion approach. | Brief Bioinform | 2025 | 40874820 | PubTator, text mining | PubMed |
| microRNA-576-5p ameliorates dexamethasone-induced BMSC injury by suppressing ANXA2. | Sci Rep | 2025 | 40836105 | PubTator, text mining | PubMed |
| The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation. | Medicina (Kaunas) | 2025 | 40142286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442891/papers?page=2